Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 300,000 shares at $42.44 ($12.5M) on 2023-09-01, disclosed to the SEC on 2023-09-01.
Open-market sale of $12.5M APLS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.70 | 139,716 | $5.8M | 46.5% |
| 2 | $41.70 | 139,716 | $5.8M | 46.5% |
| 3 | $42.44 | 10,284 | $436K | 3.5% |
| 4 | $42.44 | 10,284 | $436K | 3.5% |
| Total | $41.75 avg | 300,000 | $12.5M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |